Identification of Risk Factors for Chemotherapy-Related 30-Day Readmissions

Restricted access

Purpose: The goal of this study was to develop a method for practitioners to evaluate both quality of care delivered to patients receiving chemotherapy and illicit risk factors for 30-day chemotherapy-related readmissions (CRR). Methods: Midas+ DataVision Readmission Tool Pack (Version 2.x) was used to retrospectively identify patients who received inpatient chemotherapy from April 2010 through May 2013. The population was screened for unscheduled admissions within 30 days after discharge. A multidisciplinary team was used to attribute readmissions to chemotherapy administration. Demographic information and oncology-specific characteristics were collected. The CRR rate and relative risk for readmission were calculated for each characteristic. Results: A baseline CRR rate of 11.1% was established. Risk factors associated with an increased risk for experiencing a CRR included age of 65 years or older, hematologic cancer diagnosis, first cycle chemotherapy, Medicare coverage, discharge to a skilled nursing facility, and anthracycline administration. Conclusions: A baseline CRR rate was established. Institution-specific 30-day CRR risk factors were elucidated. Modifiable risk factors included discharge to a skilled nursing facility and administration of an anthracycline. Further investigation for opportunities for quality improvement in these 2 risk factors is a topic for future research. Expanded research into chemotherapy-related toxicities requiring inpatient admission/readmission outside of clinical trials is warranted.

Correspondence: Georgia Keriazes, PharmD, BCOP, BCPS, Lakeview Regional Health, 1324 Lakeland Hills Boulevard, Lakeland, FL 33805. E-mail: georgia.keriazes@myLRH.org
  • 1.

    Cancer Facts and Figures 2014. American cancer Society Web site. Available at: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/. Accessed June 20, 2014.

    • Search Google Scholar
    • Export Citation
  • 2.

    Horwitz L, Partovian C, Lin Z. Hospital-wide (all-condition) 30-day risk standardization readmission measure. Available at: http://www4a.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/MMS/downloads/MMSHospital-WideAll-ConditionReadmissionRate.pdf. Accessed July 25, 2013.

    • Search Google Scholar
    • Export Citation
  • 3.

    Silverstein MD, Qin H, Mercer SQ. Risk factors for 30-day hospital readmission in patients ≥ 65 years of age. Proc (Bayl Univ Med Cent) 2008;21:363372.

    • Search Google Scholar
    • Export Citation
  • 4.

    Oduyebo I, Lehmann CU, Pollack CE. Association of self-reported hospital discharge handoffs with 30-day readmissions. JAMA Intern Med 2013;173:624629.

    • Search Google Scholar
    • Export Citation
  • 5.

    Krzyzanowska MK, Treacy J, Maloney B. Development of a patient registry to evaluate hospital admissions related to chemotherapy toxicity in a community cancer center. J Oncol Pract 2005;1:1519.

    • Search Google Scholar
    • Export Citation
  • 6.

    Hassett MJ, Rao SR, Brozovic S. Chemotherapy-related hospitalizations among community cancer center patients. Oncologist 2011:16:378387.

  • 7.

    Hechenbleikner EM, Makary MA, Samarov DV. Hospital readmission by method of data collection. J Am Coll Surg 2013:216:11501158.

  • 8.

    Lyman GH, Kuderer NM, Crawford J. Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy. Cancer 2011;117:19171927.

    • Search Google Scholar
    • Export Citation
  • 9.

    Crawford J, Wolff D, Culakova Efor the ANC Study Group. First-cycle risk of severe and febrile neutropenia in cancer patients receiving systemic chemotherapy: results from a prospective nationwide study [abstract]. Poster presented at the 46th Annual ASH Meeting; December 4–7, 2004; San Diego, California. Abstract 2210.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 191 166 28
PDF Downloads 34 28 0
EPUB Downloads 0 0 0